COVID-19: Post infection implications in different age groups, mechanism, diagnosis, effective prevention, treatment, and recommendations

医学 病毒 免疫学 不利影响 免疫 肺炎 大流行 免疫系统 亚临床感染 2019年冠状病毒病(COVID-19) 冠状病毒 病毒学 重症监护医学 内科学 疾病 传染病(医学专业)
作者
Muhammad Akmal Raheem,Muhammad Ajwad Rahim,Ijaz Gul,Md. Reyad‐ul‐Ferdous,Can Yang Zhang,Dongmei Yu,Vijay Pandey,Kui Du,Runming Wang,Sanyang Han,Yuxing Han,Peiwu Qin
出处
期刊:Life Sciences [Elsevier]
卷期号:: 122861-122861
标识
DOI:10.1016/j.lfs.2024.122861
摘要

SARS-CoV-2 is a highly contagious pathogen that predominantly caused the COVID-19 pandemic. The persistent effects of COVID-19 are defined as an inflammatory or host response to the virus that begins four weeks after initial infection and persists for an undetermined length of time. Chronic effects are more harmful than acute ones thus, this review explored the long-term effects of the virus on various human organs, including the pulmonary, cardiovascular, and neurological, reproductive, gastrointestinal, musculoskeletal, endocrine, and lymphoid systems and found that SARS-CoV-2 adversely affects these organs of older adults. Regarding diagnosis, the RT-PCR is a gold standard method of diagnosing COVID-19; however, it requires specialized equipment and personnel for performing assays and a long time for results production. Therefore, to overcome these limitations, artificial intelligence employed in imaging and microfluidics technologies is the most promising in diagnosing COVID-19. Pharmacological and non-pharmacological strategies are the most effective treatment for reducing the persistent impacts of COVID-19 by providing immunity to post-COVID-19 patients by reducing cytokine release syndrome, improving the T cell response, and increasing the circulation of activated natural killer and CD8 T cells in blood and tissues, which ultimately reduces fever, nausea, fatigue, and muscle weakness and pain. Vaccines such as inactivated viral, live attenuated viral, protein subunit, viral vectored, mRNA, DNA, or nanoparticle vaccines significantly reduce the adverse long-term virus effects in post-COVID-19 patients; however, no vaccine was reported to provide lifetime protection against COVID-19; consequently, protective measures such as physical separation, mask use, and hand cleansing are promising strategies. This review provides a comprehensive knowledge of the persistent effects of COVID-19 on people of varying ages, as well as diagnosis, treatment, vaccination, and future preventative measures against the spread of SARS-CoV-2.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
lx完成签到,获得积分10
1秒前
yang完成签到 ,获得积分10
1秒前
啦啦啦啦啦啦完成签到 ,获得积分10
3秒前
JANE完成签到 ,获得积分10
4秒前
rice0601完成签到,获得积分10
6秒前
大力水手完成签到,获得积分10
6秒前
追寻念云完成签到 ,获得积分10
11秒前
小事完成签到 ,获得积分10
11秒前
务实曲奇完成签到,获得积分20
15秒前
violetlishu完成签到 ,获得积分10
16秒前
homer发布了新的文献求助10
17秒前
小糖完成签到 ,获得积分10
17秒前
刘汉淼发布了新的文献求助20
20秒前
hzl完成签到,获得积分10
21秒前
菠萝蜜完成签到,获得积分10
22秒前
skysleeper完成签到,获得积分10
24秒前
tsy完成签到 ,获得积分10
25秒前
wtt完成签到 ,获得积分10
26秒前
万能图书馆应助homer采纳,获得10
29秒前
xkhxh完成签到 ,获得积分10
30秒前
ffyzsl完成签到,获得积分10
30秒前
谢尔顿完成签到,获得积分10
31秒前
爱撒娇的孤丹完成签到 ,获得积分10
32秒前
草莓熊1215完成签到 ,获得积分10
34秒前
ycw7777完成签到,获得积分10
36秒前
搭碰完成签到,获得积分0
37秒前
ruter完成签到,获得积分0
39秒前
马大翔应助科研通管家采纳,获得20
40秒前
搜集达人应助科研通管家采纳,获得10
40秒前
77完成签到 ,获得积分10
41秒前
粉鳍完成签到 ,获得积分10
42秒前
ruiii完成签到 ,获得积分10
43秒前
homer完成签到,获得积分20
44秒前
46秒前
song完成签到 ,获得积分10
48秒前
50秒前
追寻的冬寒完成签到 ,获得积分10
55秒前
刘汉淼完成签到,获得积分10
57秒前
卡卡卡卡卡卡卡卡卡西完成签到,获得积分10
58秒前
123完成签到 ,获得积分10
58秒前
高分求助中
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Chen Hansheng: China’s Last Romantic Revolutionary 500
宽禁带半导体紫外光电探测器 388
Case Research: The Case Writing Process 300
Global Geological Record of Lake Basins 300
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3142849
求助须知:如何正确求助?哪些是违规求助? 2793757
关于积分的说明 7807197
捐赠科研通 2450021
什么是DOI,文献DOI怎么找? 1303576
科研通“疑难数据库(出版商)”最低求助积分说明 627016
版权声明 601350